Inventor
SHI BING
US42 patents
⚠️ This page may combine multiple inventors who share the name “SHI BING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD SCIENCES INC
25 patentsUS10849892B2Dec 1, 2020
Choline salt forms of an HIV capsid inhibitor
GILEAD SCIENCES INC22 citations93
US9469613B2Oct 18, 2016
(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
GILEAD SCIENCES INC15 citations91
US11613553B2Mar 28, 2023
Methods of preparing 1′-cyano nucleosides
GILEAD SCIENCES INC19 citations89
US11117886B2Sep 14, 2021
Methods and intermediates for preparing therapeutic compounds
GILEAD SCIENCES INC15 citations89
US10696657B2Jun 30, 2020
Methods and intermediates for preparing therapeutic compounds
GILEAD SCIENCES INC22 citations88
US11845739B2Dec 19, 2023
Solid forms of an HIV capsid inhibitor
GILEAD SCIENCES INC6 citations86
US11267799B2Mar 8, 2022
Solid forms of an HIV capsid inhibitor
GILEAD SCIENCES INC8 citations86
US11655237B2May 23, 2023
Solid forms of a Cot inhibitor compound
GILEAD SCIENCES INC6 citations84
US11266638B2Mar 8, 2022
Choline salt forms of an HIV capsid inhibitor
GILEAD SCIENCES INC7 citations84
US9296769B2Mar 29, 2016
Tenofovir alafenamide hemifumarate
GILEAD SCIENCES INC5 citations82
US9409891B2Aug 9, 2016
Solid forms of an antiviral compound
GILEAD SCIENCES INC5 citations81
US8841340B2Sep 23, 2014
Solid forms of an antiviral compound
GILEAD SCIENCES INC9 citations81
US12492189B2Dec 9, 2025
Solid forms of an HIV capsid inhibitor
GILEAD SCIENCES INC1 citations75
US11440928B2Sep 13, 2022
Crystalline forms of tenofovir alafenamide
GILEAD SCIENCES INC1 citations72
US10287307B2May 14, 2019
Crystalline forms of tenofovir alafenamide
GILEAD SCIENCES INC2 citations72
US11833143B2Dec 5, 2023
Choline salt forms of an HIV capsid inhibitor
GILEAD SCIENCES INC3 citations71
US9809559B2Nov 7, 2017
(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
GILEAD SCIENCES INC3 citations71
US12202849B2Jan 21, 2025
Crystalline forms of tenofovir alafenamide
GILEAD SCIENCES INC0 citations62
US10155781B2Dec 18, 2018
Co-crystals, salts and solid forms of tenofovir alafenamide
GILEAD SCIENCES INC1 citations62
US12486252B2Dec 2, 2025
Solid forms of a Cot inhibitor compound
GILEAD SCIENCES INC0 citations57
US10407438B2Sep 10, 2019
Crystalline forms of darunavir
GILEAD SCIENCES INC0 citations52
US10370381B2Aug 6, 2019
Inhibitors of bruton'S tyrosine kinase
GILEAD SCIENCES INC0 citations52
US9777028B2Oct 3, 2017
Co-crystals, salts and solid forms of tenofovir alafenamide
GILEAD SCIENCES INC1 citations51
US10851125B2Dec 1, 2020
Crystalline forms of ethyl ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl(-L-alaninate
GILEAD SCIENCES INC0 citations45
US9487546B2Nov 8, 2016
Solid forms of tenofovir
GILEAD SCIENCES INC0 citations45
GILEAD PHARMASSET LLC
8 patentsUS8969588B2Mar 3, 2015
Solid forms of an antiviral compound
GILEAD PHARMASSET LLC17 citations92
US9884873B2Feb 6, 2018
Solid forms of an antiviral compound
GILEAD PHARMASSET LLC6 citations83
US9630972B2Apr 25, 2017
Solid forms of an antiviral compound
GILEAD PHARMASSET LLC6 citations83
US10604530B2Mar 31, 2020
Solid forms of an antiviral compound
GILEAD PHARMASSET LLC2 citations72
US9682987B2Jun 20, 2017
Solid forms of an antiviral compound
GILEAD PHARMASSET LLC2 citations72
US9340568B2May 17, 2016
Solid forms of an antiviral compound
GILEAD PHARMASSET LLC4 citations66
US11203599B2Dec 21, 2021
Solid forms of an antiviral compound
GILEAD PHARMASSET LLC0 citations62
US9139570B2Sep 22, 2015
Solid forms of an antiviral compound
GILEAD PHARMASSET LLC3 citations62
GILEAD CALISTOGA LLC
3 patentsUS8865730B2Oct 21, 2014
Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
GILEAD CALISTOGA LLC25 citations91
US9469643B2Oct 18, 2016
Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
GILEAD CALISTOGA LLC9 citations82
US10730879B2Aug 4, 2020
Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
GILEAD CALISTOGA LLC2 citations71